Business as unusual: medical oncology services adapt and deliver during <scp>COVID</scp>‐19Avraham Travers, James Lynam, Kim Adler et al.|Internal Medicine Journal|2021Cited by 9
Abstract CT084: A phase 1 study of LY4101174 (ETx-22), an antibody-drug conjugate targeting nectin-4, in patients with advanced or metastatic urothelial cancer and other solid tumors (trial in progress)Jonathan E. Rosenberg, Ahmad Awada, Matthew D. Galsky et al.|Cancer Research|2024Cited by 9
Multi-Arm GlioblastoMa Australasia (MAGMA): protocol for a multiarm randomised clinical trial for people affected by glioblastomaBenjamin Y. Kong, Craig Gedye, Hao‐Wen Sim et al.|BMJ Open|2022Cited by 7
Chemoradiotherapy with concurrent durvalumab for the palliative treatment of oligometastatic oesophageal and gastrooesophageal carcinoma with dysphagia: a single arm phase II clinical trial (PALEO, sponsored by the Australasian Gastro-Intestinal Trials Group)Fiona Day, Jarad Martin, Swetha Sridharan et al.|BMC Cancer|2022Cited by 6
The impact of integrating an oncology nurse practitioner into an acute care hospital emergency department: An Australian tertiary cancer centre experience.Gillian Blanchard, Hiren Mandaliya, Antonino Bonaventura et al.|Journal of Clinical Oncology|2020Cited by 2